Finance

Lists
Why is INAB down 10,82%?
Dive Deeper
INAB:NASDAQ
IN8bio Inc
0,83 USD
-10,82%
(-0,10) 1D
0,84 USD
+1,20% (+0,0100)
After hours
Closed: 5-ноя., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INAB...
Open
0,90 USD
High
0,90 USD
Low
0,80 USD
Mkt. cap
8,19 млн
Avg. vol.
48,90 миң
Volume
43,01 миң
52-wk high
2,72 USD
52-wk low
0,80 USD
EPS
-2,05 USD
Beta
0,28
Shares outstanding
9,86 млн
No. of employees
18
Open
0,90 USD
High
0,90 USD
Low
0,80 USD
Mkt. cap
8,19 млн
Avg. vol.
48,90 миң
Volume
43,01 миң
52-wk high
2,72 USD
52-wk low
0,80 USD
EPS
-2,05 USD
Beta
0,28
Shares outstanding
9,86 млн
No. of employees
18
News stories
From web sources and news partners
About IN8bio Inc
CEO-
Employees18
Founded2016
Headquarters-
SectorHealth Care
Industry-
Websitein8bio.com
Analyst ratings
Based on 2 analysts giving stock ratings to INAB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INAB in the last 3 months.
Highest
Current 0,83 USD
6,00 USD (+622,89%)
Average
5,50 USD (+562,65%)
Lowest
5,00 USD (+502,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
6,00 USD
+622,9%
10/01/2026
Uy Ear
Mizuho Securities
Buy
Maintained
4,00 USD
+381,9%
08/11/2026
Boris Peaker
JonesTrading
Buy
Maintained
5,00 USD
+502,4%
08/07/2026
Soumit Roy
JonesTrading
Buy
Maintained
5,00 USD
+502,4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,10 млн
2,65 млн
2,61 млн
2,49 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,86 млн
2,38 млн
2,65 млн
2,44 млн
Operating expense
3,97 млн
5,03 млн
5,27 млн
4,94 млн
Total operating expenses
3,97 млн
5,03 млн
5,27 млн
4,94 млн
Operating income
-3,97 млн
-5,03 млн
-5,27 млн
-4,94 млн
Other non operating income
-
-
-
-
EBT including unusual items
-3,85 млн
-4,94 млн
-5,09 млн
-4,78 млн
EBT excluding unusual items
-3,85 млн
-4,94 млн
-5,09 млн
-4,78 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,85 млн
-4,94 млн
-5,09 млн
-4,78 млн
Net profit margin
-
-
-
-
Earnings per share
-0,85
-0,45
-0,26
-0,25
Interest and investment income
113,00 миң
91,00 миң
176,00 миң
154,00 миң
Interest expense
-
-
-
-
Net interest expenses
113,00 миң
91,00 миң
176,00 миң
154,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,60 млн
-4,67 млн
-4,91 млн
-4,62 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору